BackOncolytics Biotech Overview
Oncolytics Biotech, Inc.

Oncolytics Biotech Discounted Cash Flow

DCF Analysis for ONCY.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.05

Current Fair Value

$0.05
94.5% Downside

Overvalued by 94.5% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading